BioCorRx Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $139.4K | $88.0K | $65.2K | $68.6K | $85.8K | $592.1K | $2.6M | $279.8K |
| Accounts Receivable | $253.5K | $0 | $740 | $35.4K | — | — | — | — |
| Inventory | $143.4K | $0 | — | — | — | — | — | — |
| Total Current Assets | $814.5K | $118.0K | $187.1K | $316.9K | $228.3K | $974.9K | $3.0M | $319.2K |
| Property, Plant & Equipment | $4.1K | $19.0K | $50.9K | $76.6K | $102.8K | $128.6K | $148.3K | $44.4K |
| Goodwill | $563.2K | $0 | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $564.5K | $7.8K | $9.0K | $10.2K | $0 | $176.9K | $224.0K | — |
| Total Assets | $2.1M | $385.9K | $388.9K | $766.6K | $820.0K | $1.8M | $3.9M | $628.2K |
| Liabilities | ||||||||
| Accounts Payable | $4.0M | $3.0M | $2.5M | $2.0M | $1.8M | $1.2M | $709.4K | $655.7K |
| Total Current Liabilities | $8.3M | $8.2M | $6.4M | $5.4M | $4.4M | $3.1M | $2.6M | $6.1M |
| Long-Term Debt | — | — | — | $0 | $99.9K | — | — | — |
| Total Liabilities | $13.7M | $12.7M | $10.3M | $9.0M | $7.8M | $6.0M | $5.0M | $6.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-86.6M | $-83.2M | $-78.1M | $-74.3M | $-70.0M | $-64.7M | $-61.2M | $-55.2M |
| Total Stockholders' Equity | $-11.2M | $-12.1M | $-9.8M | $-8.1M | $-7.0M | $-4.2M | $-1.1M | $-5.7M |